Business · 13/08/1999Updated: 10/17/2026 · 1 min read
FDA to Discuss Vibrio Parahaemolyticus Risk Assessment Model
Summary
The FDA, in collaboration with the National Advisory Committee on Microbiological Criteria for Foods and the FSIS/USDA, is hosting a public meeting to discuss a preliminary risk assessment model examining the link between Vibrio parahaemolyticus and human health.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →